Save the Date – SECURE Special Event

We are pleased to invite you to the SECURE Project Special Event: “Advancing in Supply, Safety and Strength in Radioisotopes Production and Use for Nuclear Medicine: Innovations and Perspectives“. An event dedicated to the future of medical isotope production and its critical role in cancer diagnose and treatment, aligning with key European initiatives.

 📆 Date: 28th May 2025

 📍 Venue: Fondation Universitaire Stichting, Rue d’Egmont 11, Brussels 1000, Belgium & Online

Background

The use of nuclear medicine is strongly increasing, with new nuclear medicines for therapy, diagnostics and theranostics being developed. Europe has a strong position in nuclear medicine in the clinical environment and the supply chain. To maintain that supply chain position for future nuclear medical developments, efforts must be made to strengthen the nuclear medical knowledge infrastructure. By doing innovation and research, and by securing future human capital through education and training.  The importance of ensuring reliable and safe radioisotope production for public health within nuclear medicine and radioisotope application has been documented.

Key Topics

• Advancements in alpha- and beta-emitting isotopes, including their safe production and application
• Bridging the gap between research, industry, and healthcare providers to enhance the availability of medical isotopes
• The SECURE Project’s contributions to addressing production challenges and upscaling isotope supply

This event serves as a platform to exchange knowledge and explore synergies between ongoing European efforts to enhance medical isotope availability and safety.

Registration

Please register for the event here: Register Here

For more information, visit the ENEN website: SECURE Project Overview

We look forward to welcoming you to this important discussion on the future of nuclear medicine!

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Atomic Energy Community (EC-Euratom). Neither the European Union nor the granting authority can be held responsible for them.